RoActemra (tocilizumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RoActemra (tocilizumab), covering 2013-01-17 to 2013-01-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy [Phase 3]